OTO-104 for the Treatment of Meniere's Disease

NCT01412177 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Meniere's Disease

Interventions

DRUG: OTO-104
DRUG: Placebo

Sponsor

Otonomy, Inc.